Hydrus Microstent for Refractory Open-Angle Glaucoma
Public ClinicalTrials.gov record NCT03267134. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Hydrus Microstent for Refractory Open-Angle Glaucoma: A Prospective, Multicenter Clinical Trial (Hydrus VII Study)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the safety and effectiveness of the Hydrus Microstent in patients with refractory open-angle glaucoma.
Study identification
- NCT ID
- NCT03267134
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 217 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2017
- Primary completion
- Dec 15, 2022
- Completion
- Dec 15, 2022
- Last update posted
- Jan 13, 2026
2017 – 2022
United States locations
- U.S. sites
- 16
- U.S. states
- 10
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vold Vision | Fayetteville | Arkansas | 72704 | — |
| Sacramento Eye Consultants | Sacramento | California | 95815 | — |
| Eye Center of Northern Colorado | Fort Collins | Colorado | 80528 | — |
| Ocala Eye | Ocala | Florida | 34474 | — |
| Center for Sight | Venice | Florida | 34283 | — |
| Stiles Eyecare | Overland Park | Kansas | 66213 | — |
| Louisiana Eye and Laser Center | Alexandria | Louisiana | 71303 | — |
| Washington University in St. Louis Ophthalmology | St Louis | Missouri | 63110 | — |
| Scott & Christie and Associates | Cranberry Township | Pennsylvania | 16066 | — |
| Texan Eye | Austin | Texas | 78731 | — |
| Glaucoma Associates of Texas | Dallas | Texas | 75231 | — |
| El Paso Eye Surgeons | El Paso | Texas | 79902 | — |
| Ophthalmology Associates | Fort Worth | Texas | 76102 | — |
| Vale-Asche Russell Clinical Research Center | Houston | Texas | 77030 | — |
| R and R Research, LLC | San Antonio | Texas | 78229 | — |
| The Eye Centers of Racine and Kenosha | Kenosha | Wisconsin | 53142 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
Recently updated Open-angle Glaucoma trials
Other public records listing Open-angle Glaucoma. Sorted by last update posted; newest first. Not a recommendation.
- NCT05506423: Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes Active, not recruiting
- NCT07619482: Topical Insulin for Glaucoma (TING2) Not yet recruiting
- NCT07325240: 24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients Recruiting
- NCT04499248: AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension Recruiting
- NCT07217678: Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use Recruiting
- NCT07228221: Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03267134, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03267134 live on ClinicalTrials.gov.